Familial Investigations of Childhood Cancer Predisposition

Part of paid clinical trials in Memphis, Tennessee.

Sponsor
St. Jude Children's Research Hospital
Study ID
NCT03050268
Status
Recruiting
Apply to this trial

Conditions

  • AML
  • Acute Leukemia
  • Adenomatous Polyposis
  • Adrenocortical Carcinoma
  • BAP1 Tumor Predisposition Syndrome
  • Carney Complex
  • Choroid Plexus Carcinoma
  • Constitutional Mismatch Repair Deficiency Syndrome
  • DICER1 Syndrome
  • Diamond-Blackfan Anemia
  • Dyskeratosis Congenita
  • Emberger Syndrome
  • Familial Acute Myeloid Leukemia
  • Familial Adenomatous Polyposis
  • Familial Cancer
  • Familial Neuroblastoma
  • Familial Wilms Tumor
  • Fanconi Anemia
  • GIST
  • Hereditary Breast and Ovarian Cancer
  • Hereditary Paraganglioma-Pheochromocytoma Syndrome
  • Hodgkin Lymphoma
  • Juvenile Polyposis
  • Li-Fraumeni Syndrome
  • Lynch Syndrome
  • MDS
  • Melanoma Syndrome
  • Multiple Endocrine Neoplasia Type 1
  • Multiple Endocrine Neoplasia Type 2
  • Neuroblastoma
  • Neurofibromatosis Type 1
  • Neurofibromatosis Type II
  • Nevoid Basal Cell Carcinoma Syndrome
  • Non Hodgkin Lymphoma
  • Noonan Syndrome and Other Rasopathy
  • Overgrowth Syndromes
  • PTEN Hamartoma Tumor Syndrome
  • Pancreatic Cancer
  • Peutz-Jeghers Syndrome
  • Pheochromocytoma/Paraganglioma
  • Retinoblastoma
  • Rhabdoid Tumor Predisposition Syndrome
  • Rhabdomyosarcoma
  • Rothmund-Thomson Syndrome
  • Tuberous Sclerosis
  • Von Hippel-Lindau Disease

Eligibility Criteria

Sex
ALL
Age
N/A - N/A
Healthy Volunteers
Not accepted

Study Details

NOTE: This is a research study and is not meant to be a substitute for clinical genetic testing. Families may never receive results from the study or may receive results many years from the time they enroll. If you are interested in clinical testing please consider seeing a local genetic counselor or other genetics professional. If you have already had clinical genetic testing and meet eligibility criteria for this study as shown in the Eligibility Section, you may enroll regardless of the results of your clinical genetic testing. While it is well recognized that hereditary factors contribute to the development of a subset of human cancers, the cause for many cancers remains unknown. The application of next generation sequencing (NGS) technologies has expanded knowledge in the field of hereditary cancer predisposition. Currently, more than 100 cancer predisposing genes have been identified, and it is now estimated that approximately 10% of all cancer patients have an underlying genetic predisposition. The purpose of this protocol is to identify novel cancer predisposing genes and/or genetic variants. For this study, the investigators will establish a Data Registry linked to a Repository of biological samples. Health information, blood samples and occasionally leftover tumor samples will be collected from individuals with familial cancer. The investigators will use NGS approaches to find changes in genes that may be important in the development of familial cancer. The information gained from this study may provide new and better ways to diagnose and care for people with hereditary cancer. PRIMARY OBJECTIVE: * Establish a registry of families with clustering of cancer in which clinical data are linked to a repository of cryopreserved blood cells, germline DNA, and tumor tissues from the proband and other family members. SECONDARY OBJECTIVE: * Identify novel cancer predisposing genes and/or genetic variants in families with clustering of cancer for which the underlying genetic basis is unknown.

Key Dates

Start date
Apr 6, 2017
Status verified
Apr 2026
Primary completion
Mar 31, 2037
Completion
Mar 31, 2037

Study Design

Enrollment
1,500 participants (estimated)

Primary Outcome Measure

Identification of novel cancer predisposing genes [ Time Frame: Up to 20 years following study activation ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
St. Jude Children's Research HospitalMemphisTennessee38105
Kim E. Nichols, MD
[email protected]
888-226-4343
Kim E. Nichols, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Memphis, TN

By condition
Leukemia (other)NeuroblastomaPancreatic cancer
By specialty
OncologyBlood cancerPediatric oncologyGI oncology
By research site
St. Jude Children's Research Hospital· Memphis, TN

Related Studies